Clinical trial
Optimum Platelet Inhibition After Coronary Bypass Surgery
NCT00262275 · Papworth Hospital NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00262275 |
|---|---|
| Title | Optimum Platelet Inhibition After Coronary Bypass Surgery |
| Official title | Optimum Platelet Inhibition After Coronary Artery Bypass Surgery: A Randomised Trial Comparing Platelet Aggregation Using Low, Medium Dose Aspirin and Clopidogrel |
| Lead sponsor | Papworth Hospital NHS Foundation Trust, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ischemic Heart Disease |
| Intervention type | Drug |
| Interventions | Aspirin, Clopidogrel |
| Start date | Jul 1, 2002 |
| Primary completion | Jul 1, 2004 |
| First posted | Dec 6, 2005 |
| Last update posted | Jan 22, 2016 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: